ACER THERAPEUTICS INC's ticker is ACER and the CUSIP is 00444P108. A total of 41 filers reported holding ACER THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $449 | -99.8% | 179 | 0.0% | 0.00% | – |
| Q3 2022 | $249,000 | +10.2% | 179 | 0.0% | 0.00% | – |
| Q2 2022 | $226,000 | -56.5% | 179 | 0.0% | 0.00% | – |
| Q1 2022 | $519,000 | +26.0% | 179 | 0.0% | 0.00% | – |
| Q4 2021 | $412,000 | -9.6% | 179 | 0.0% | 0.00% | – |
| Q3 2021 | $456,000 | -10.9% | 179 | 0.0% | 0.00% | – |
| Q2 2021 | $512,000 | -8.1% | 179 | 0.0% | 0.00% | – |
| Q1 2021 | $557,000 | +18.8% | 179 | 0.0% | 0.00% | – |
| Q4 2020 | $469,000 | -9.1% | 179 | 0.0% | 0.00% | – |
| Q3 2020 | $516,000 | -98.5% | 179 | -98.2% | 0.00% | – |
| Q2 2020 | $34,746,000 | +1025.9% | 10,130 | +553.1% | 0.00% | – |
| Q1 2020 | $3,086,000 | +9.9% | 1,551 | +121.6% | 0.00% | – |
| Q4 2019 | $2,807,000 | +254.9% | 700 | +182.3% | 0.00% | – |
| Q3 2019 | $791,000 | +1451.0% | 248 | +1807.7% | 0.00% | – |
| Q2 2019 | $51,000 | – | 13 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nantahala Capital Management | 1,136,416 | $1,049,367 | 0.10% |
| Anson Funds Management LP | 129,795 | $119,853 | 0.02% |
| HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC | 60,000 | $55 | 0.01% |
| Hudson Bay Capital Management LP | 274,300 | $253,289 | 0.00% |
| UBS Group AG | 33 | $30 | 0.00% |
| RHUMBLINE ADVISERS | 347 | $320 | 0.00% |
| OSAIC HOLDINGS, INC. | 200 | $184 | 0.00% |
| WELLS FARGO & COMPANY/MN | 132 | $122 | 0.00% |
| NORTHERN TRUST CORP | 22,231 | $20,528 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |